COMMUNIQUÉS West-GlobeNewswire

-
U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide
29/04/2019 -
EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting
29/04/2019 -
MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer
29/04/2019 -
Hendrick Health System selects Allscripts to provide single patient record, billing and database solution
29/04/2019 -
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
29/04/2019 -
Teneobio Announces US FDA Approval of the Investigational New Drug Application for TNB-383B and the Initiation of Phase I Clinical Studies in Multiple Myeloma Patients
29/04/2019 -
Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
29/04/2019 -
Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer
29/04/2019 -
Evolus to Participate in Two Upcoming Investor Conferences
29/04/2019 -
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 6, 2019
29/04/2019 -
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
29/04/2019 -
Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader
29/04/2019 -
Scott Shuda Appointed to IRIDEX Board of Directors
29/04/2019 -
Extendicare Announces Timing of 2019 First Quarter Results and Conference Call
29/04/2019 -
LogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic Acidemia
29/04/2019 -
Medovex Corporation Announces Recent Management Appointments
29/04/2019 -
ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors
29/04/2019 -
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
29/04/2019 -
Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan
29/04/2019
Pages